Yanli Lan

机构：Hubei University of Arts and Science, Chengdu Fifth People's Hospital · ORCID：0000-0001-7289-1605

发表论文 18 篇 · 总被引 313 次 · h-index 8

代表论文

• Metformin treatment alleviates polycystic ovary syndrome by decreasing the expression of MMP‐2 and MMP‐9 via H19/miR‐29b‐3p and AKT/mTOR/autophagy signaling pathways (2019 · Journal of Cellular Physiology · 被引 85)
• Necrostatin-1 inhibits Hmgb1-IL-23/IL-17 pathway and attenuates cardiac ischemia reperfusion injury (2014 · Transplant International · 被引 56)
• Chemerin promotes the pathogenesis of preeclampsia by activating CMKLR1/p-Akt/CEBPɑ axis and inducing M1 macrophage polarization (2021 · Cell Biology and Toxicology · 被引 46)
• Serum chemerin level during the first trimester of pregnancy and the risk of gestational diabetes mellitus (2017 · Gynecological Endocrinology · 被引 34)
• Serum chemerin level in women with PCOS and its relation with the risk of spontaneous abortion (2018 · Gynecological Endocrinology · 被引 26)
• Role of chemerin/CMKLR1 in the maintenance of early pregnancy (2018 · Frontiers of Medicine · 被引 24)